Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

218 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact of adjuvant sorafenib treatment after local ablation for HCC in the phase II SORAMIC trial.
Seidensticker M, Öcal O, Schütte K, Malfertheiner P, Berg T, Loewe C, Klümpen HJ, van Delden O, Ümütlü MR, Ben Khaled N, de Toni EN, Seidensticker R, Aghdassi A, Tran A, Bronowicki JP, Peynircioglu B, Sangro B, Pech M, Ricke J. Seidensticker M, et al. Among authors: van delden o. JHEP Rep. 2023 Feb 15;5(5):100699. doi: 10.1016/j.jhepr.2023.100699. eCollection 2023 May. JHEP Rep. 2023. PMID: 36968218 Free PMC article.
The value of sorafenib trough levels in patients with advanced hepatocellular carcinoma - a substudy of the SORAMIC trial.
Labeur TA, Hofsink Q, Takkenberg RB, van Delden OM, Mathôt RAA, Schinner R, Malfertheiner P, Amthauer H, Schütte K, Basu B, Kuhl C, Mayerle J, Ricke J, Klümpen HJ. Labeur TA, et al. Acta Oncol. 2020 Sep;59(9):1028-1035. doi: 10.1080/0284186X.2020.1759826. Epub 2020 May 5. Acta Oncol. 2020. PMID: 32366155 Free article. Clinical Trial.
Gadoxetic acid-based hepatobiliary MRI in hepatocellular carcinoma.
Ricke J, Steffen IG, Bargellini I, Berg T, Bilbao Jaureguizar JI, Gebauer B, Iezzi R, Loewe C, Karçaaltincaba M, Pech M, Sengel C, van Delden O, Vandecaveye V, Zech CJ, Seidensticker M. Ricke J, et al. Among authors: van delden o. JHEP Rep. 2020 Aug 24;2(6):100173. doi: 10.1016/j.jhepr.2020.100173. eCollection 2020 Dec. JHEP Rep. 2020. PMID: 33103093 Free PMC article.
Correlation of liver enhancement in gadoxetic acid-enhanced MRI with liver functions: a multicenter-multivendor analysis of hepatocellular carcinoma patients from SORAMIC trial.
Öcal O, Peynircioglu B, Loewe C, van Delden O, Vandecaveye V, Gebauer B, Zech CJ, Sengel C, Bargellini I, Iezzi R, Benito A, Schütte K, Gasbarrini A, Seidensticker R, Wildgruber M, Pech M, Malfertheiner P, Ricke J, Seidensticker M. Öcal O, et al. Among authors: van delden o. Eur Radiol. 2022 Feb;32(2):1320-1329. doi: 10.1007/s00330-021-08218-9. Epub 2021 Aug 31. Eur Radiol. 2022. PMID: 34467453 Free PMC article.
Gadoxetic acid uptake as a molecular imaging biomarker for sorafenib resistance in patients with hepatocellular carcinoma: a post hoc analysis of the SORAMIC trial.
Öcal O, Rössler D, Gasbarrini A, Berg T, Klümpen HJ, Bargellini I, Peynircioglu B, van Delden O, Schulz C, Schütte K, Iezzi R, Pech M, Malfertheiner P, Sangro B, Ricke J, Seidensticker M. Öcal O, et al. Among authors: van delden o. J Cancer Res Clin Oncol. 2022 Sep;148(9):2487-2496. doi: 10.1007/s00432-021-03803-3. Epub 2021 Sep 20. J Cancer Res Clin Oncol. 2022. PMID: 34541612 Free PMC article. Clinical Trial.
Prognostic value of baseline imaging and clinical features in patients with advanced hepatocellular carcinoma.
Öcal O, Ingrisch M, Ümütlü MR, Peynircioglu B, Loewe C, van Delden O, Vandecaveye V, Gebauer B, Zech CJ, Sengel C, Bargellini I, Iezzi R, Benito A, Pech M, Malfertheiner P, Ricke J, Seidensticker M. Öcal O, et al. Among authors: van delden o. Br J Cancer. 2022 Feb;126(2):211-218. doi: 10.1038/s41416-021-01577-6. Epub 2021 Oct 22. Br J Cancer. 2022. PMID: 34686780 Free PMC article. Clinical Trial.
Early tumor shrinkage and response assessment according to mRECIST predict overall survival in hepatocellular carcinoma patients under sorafenib.
Öcal O, Schinner R, Schütte K, de Toni EN, Loewe C, van Delden O, Vandecaveye V, Gebauer B, Zech CJ, Sengel C, Bargellini I, Gasbarrini A, Sangro B, Pech M, Malfertheiner P, Ricke J, Seidensticker M; SORAMIC study group. Öcal O, et al. Among authors: van delden o. Cancer Imaging. 2022 Jan 4;22(1):1. doi: 10.1186/s40644-021-00439-x. Cancer Imaging. 2022. PMID: 34983668 Free PMC article.
Gadoxetic Acid-Based MRI for Decision-Making in Hepatocellular Carcinoma Employing Perfusion Criteria Only-A Post Hoc Analysis from the SORAMIC Trial Diagnostic Cohort.
Seidensticker M, Steffen IG, Bargellini I, Berg T, Benito A, Gebauer B, Iezzi R, Loewe C, Karçaaltincaba M, Pech M, Sengel C, van Delden O, Vandecaveye V, Zech CJ, Ricke J. Seidensticker M, et al. Among authors: van delden o. Curr Oncol. 2022 Jan 27;29(2):565-577. doi: 10.3390/curroncol29020051. Curr Oncol. 2022. PMID: 35200551 Free PMC article. Clinical Trial.
218 results